SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-559449
Filing Date
2016-04-27
Accepted
2016-04-27 16:05:38
Documents
5
Period of Report
2016-06-15
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d129480ddef14a.htm DEF 14A 292654
2 GRAPHIC g129480g02e61.jpg GRAPHIC 2498
3 GRAPHIC g129480g25j56.jpg GRAPHIC 36880
4 GRAPHIC g129480g35g96.jpg GRAPHIC 31248
5 GRAPHIC g129480g92c79.jpg GRAPHIC 2003
  Complete submission text file 0001193125-16-559449.txt   394131
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 161595365
SIC: 2834 Pharmaceutical Preparations